Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C14H20O2 |
| Molecular Weight | 220.3074 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC(C(O)=O)C1=CC=C(CC(C)C)C=C1
InChI
InChIKey=UULSXYSSHHRCQK-UHFFFAOYSA-N
InChI=1S/C14H20O2/c1-4-13(14(15)16)12-7-5-11(6-8-12)9-10(2)3/h5-8,10,13H,4,9H2,1-3H3,(H,15,16)
| Molecular Formula | C14H20O2 |
| Molecular Weight | 220.3074 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Butibufen is a non-steroidal anti-inflammatory cyclooxygenase inhibitor with analgesic and antipyretic properties. The drug was investigated for the treatment of osteoarthritis, rheumatoid artritis, and other arthroses. It was marketed under tradenames Mijal and Butilopan but now is withdrawn from the market.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL2094253 Sources: https://www.ncbi.nlm.nih.gov/pubmed/10579692 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 08:45:13 GMT 2025
by
admin
on
Wed Apr 02 08:45:13 GMT 2025
|
| Record UNII |
JSS1TEM917
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C257
Created by
admin on Wed Apr 02 08:45:13 GMT 2025 , Edited by admin on Wed Apr 02 08:45:13 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
100000088627
Created by
admin on Wed Apr 02 08:45:13 GMT 2025 , Edited by admin on Wed Apr 02 08:45:13 GMT 2025
|
PRIMARY | |||
|
SUB06015MIG
Created by
admin on Wed Apr 02 08:45:13 GMT 2025 , Edited by admin on Wed Apr 02 08:45:13 GMT 2025
|
PRIMARY | |||
|
447
Created by
admin on Wed Apr 02 08:45:13 GMT 2025 , Edited by admin on Wed Apr 02 08:45:13 GMT 2025
|
PRIMARY | |||
|
55837-18-8
Created by
admin on Wed Apr 02 08:45:13 GMT 2025 , Edited by admin on Wed Apr 02 08:45:13 GMT 2025
|
PRIMARY | |||
|
m2799
Created by
admin on Wed Apr 02 08:45:13 GMT 2025 , Edited by admin on Wed Apr 02 08:45:13 GMT 2025
|
PRIMARY | Merck Index | ||
|
JSS1TEM917
Created by
admin on Wed Apr 02 08:45:13 GMT 2025 , Edited by admin on Wed Apr 02 08:45:13 GMT 2025
|
PRIMARY | |||
|
DTXSID201021603
Created by
admin on Wed Apr 02 08:45:13 GMT 2025 , Edited by admin on Wed Apr 02 08:45:13 GMT 2025
|
PRIMARY | |||
|
CHEMBL454450
Created by
admin on Wed Apr 02 08:45:13 GMT 2025 , Edited by admin on Wed Apr 02 08:45:13 GMT 2025
|
PRIMARY | |||
|
C73083
Created by
admin on Wed Apr 02 08:45:13 GMT 2025 , Edited by admin on Wed Apr 02 08:45:13 GMT 2025
|
PRIMARY | |||
|
19880
Created by
admin on Wed Apr 02 08:45:13 GMT 2025 , Edited by admin on Wed Apr 02 08:45:13 GMT 2025
|
PRIMARY | RxNorm | ||
|
41643
Created by
admin on Wed Apr 02 08:45:13 GMT 2025 , Edited by admin on Wed Apr 02 08:45:13 GMT 2025
|
PRIMARY | |||
|
C012797
Created by
admin on Wed Apr 02 08:45:13 GMT 2025 , Edited by admin on Wed Apr 02 08:45:13 GMT 2025
|
PRIMARY | |||
|
3657
Created by
admin on Wed Apr 02 08:45:13 GMT 2025 , Edited by admin on Wed Apr 02 08:45:13 GMT 2025
|
PRIMARY | |||
|
259-849-2
Created by
admin on Wed Apr 02 08:45:13 GMT 2025 , Edited by admin on Wed Apr 02 08:45:13 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ENANTIOMER -> RACEMATE | |||
|
|
ENANTIOMER -> RACEMATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |